Global and Chinese Cardiovascular Devices Industry – 2017 – Cardiovascular Devices, Healthcare, Medical Devices Industries

The Global and Chinese Cardiovascular Devices Industry – 2017 Report has been published. It provides updated in 2018 year analysis of industries from Cardiovascular Devices, Healthcare, Medical Devices Markets.

The 'Global and Chinese Cardiovascular Devices Industry – 2017' is a professional and in-depth study on the current state of the global Cardiovascular Devices industry with a focus on the Chinese market. The report provides key statistics on the market status of the Cardiovascular Devices manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

Firstly, the report provides a basic overview of the industry including its definition, applications and manufacturing technology. Then, the report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2012-2017 market shares for each company.

Through the statistical analysis, the report depicts the global and Chinese total market of the Cardiovascular Devices industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, and by application/type for the competitive landscape analysis. The report then estimates 2017-2022 market development trends of the Cardiovascular Devices industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out.

In the end, the report makes some important proposals for a new project of the Cardiovascular Devices Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of 2012-2022 global and Chinese Cardiovascular Devices industry covering all important parameters.

PLEASE NOTE: This report will be completed after order and will take approximately 2-3 business days after the confirmation of payment.

Read more and order at Global and Chinese Cardiovascular Devices Industry – 2017

Read More

Global and Chinese Cardiovascular Devices Industry – 2017 – Cardiovascular Devices, Healthcare, Medical Devices Industries

The Global and Chinese Cardiovascular Devices Industry – 2017 Report has been published. It provides updated in 2018 year analysis of industries from Cardiovascular Devices, Healthcare, Medical Devices Markets.

The 'Global and Chinese Cardiovascular Devices Industry – 2017' is a professional and in-depth study on the current state of the global Cardiovascular Devices industry with a focus on the Chinese market. The report provides key statistics on the market status of the Cardiovascular Devices manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

Firstly, the report provides a basic overview of the industry including its definition, applications and manufacturing technology. Then, the report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2012-2017 market shares for each company.

Through the statistical analysis, the report depicts the global and Chinese total market of the Cardiovascular Devices industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, and by application/type for the competitive landscape analysis. The report then estimates 2017-2022 market development trends of the Cardiovascular Devices industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out.

In the end, the report makes some important proposals for a new project of the Cardiovascular Devices Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of 2012-2022 global and Chinese Cardiovascular Devices industry covering all important parameters.

PLEASE NOTE: This report will be completed after order and will take approximately 2-3 business days after the confirmation of payment.

Read more and order at Global and Chinese Cardiovascular Devices Industry – 2017

Read More

Asia-Pacific Clot Management Devices Market Outlook to 2021 – Cardiovascular Devices, Healthcare, Medical Devices Industries

The Asia-Pacific Clot Management Devices Market Outlook to 2021 Report has been published. It provides updated in 2018 year analysis of industries from Cardiovascular Devices, Healthcare, Medical Devices Markets.

Asia-Pacific Clot Management Devices Market Outlook to 2021

Summary

Our new report, Asia-Pacific Clot Management Devices Market Outlook to 2021, provides key market data on the Asia-Pacific Clot Management Devices market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments – Peripheral Venous Thrombectomy Devices and Embolectomy Balloon Catheters.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and countries in the region, information related to pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. We use epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

– Market size for Clot Management Devices market segments – Peripheral Venous Thrombectomy Devices and Embolectomy Balloon Catheters.
– Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
– 2014 company shares and distribution shares data for Clot Management Devices market.
– Global corporate-level profiles of key companies operating within the Asia-Pacific Clot Management Devices market.
– Key players covered include Medtronic plc, Teleflex Incorporated, Boston Scientific Corporation, Terumo Corporation and Others.

Reasons to buy

– Develop business strategies by identifying the key market segments poised for strong growth in the future.
– Develop market-entry and market expansion strategies.
– Design competition strategies by identifying who-stands-where in the market.
– Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
– What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Read more and order at Asia-Pacific Clot Management Devices Market Outlook to 2021

Read More

Plastic Prefillable Syringes – Healthcare, Medical Devices, Needles and Syringes Industries

The Plastic Prefillable Syringes Report has been published. It provides updated in 2018 year analysis of industries from Healthcare, Medical Devices, Needles and Syringes Markets.

The trend toward patient self-administration of injectables continues to have a broad influence on the drug delivery sector. While prefillable syringe manufacturers continue to improve and refine their products, from a materials technology standpoint the most dynamic developments are occurring in the refinement of PFS constructed of plastic rather than glass. To date, plastic PFS have made significant inroads in EMS injectables, a segment dominated by Hospira’s Ansyr plastic PFS product line. Now, as materials technology continues to advance, market sector participants are targeting mainstream therapeutic drugs.

Highlights

– What injectable drugs are currently delivered in plastic prefillable syringes, what are the device specifics, and who markets them?
– Who are the important plastic prefillable syringe suppliers, their manufacturing infrastructure and locations, their capabilities?
– What are the major factors driving plastic prefillable syringe demand?
– How important are drug developer-device manufacturer relationships and what are the key alliances in the industry?
– What are the essential design factors, material selection issues, technologies and market development issues for plastic prefillable syringe drug products?
– How are plastic prefillable syringes aligned with various drug classes and therapeutic markets?
– What are the significant economic, technology, and regulatory factors affecting plastic prefillable syringes?

Read more and order at Plastic Prefillable Syringes

Read More

Plastic Prefillable Syringes – Healthcare, Medical Devices, Needles and Syringes Industries

The Plastic Prefillable Syringes Report has been published. It provides updated in 2018 year analysis of industries from Healthcare, Medical Devices, Needles and Syringes Markets.

The trend toward patient self-administration of injectables continues to have a broad influence on the drug delivery sector. While prefillable syringe manufacturers continue to improve and refine their products, from a materials technology standpoint the most dynamic developments are occurring in the refinement of PFS constructed of plastic rather than glass. To date, plastic PFS have made significant inroads in EMS injectables, a segment dominated by Hospira’s Ansyr plastic PFS product line. Now, as materials technology continues to advance, market sector participants are targeting mainstream therapeutic drugs.

Highlights

– What injectable drugs are currently delivered in plastic prefillable syringes, what are the device specifics, and who markets them?
– Who are the important plastic prefillable syringe suppliers, their manufacturing infrastructure and locations, their capabilities?
– What are the major factors driving plastic prefillable syringe demand?
– How important are drug developer-device manufacturer relationships and what are the key alliances in the industry?
– What are the essential design factors, material selection issues, technologies and market development issues for plastic prefillable syringe drug products?
– How are plastic prefillable syringes aligned with various drug classes and therapeutic markets?
– What are the significant economic, technology, and regulatory factors affecting plastic prefillable syringes?

Read more and order at Plastic Prefillable Syringes

Read More

Plastic Prefillable Syringes – Healthcare, Medical Devices, Needles and Syringes Industries

The Plastic Prefillable Syringes Report has been published. It provides updated in 2018 year analysis of industries from Healthcare, Medical Devices, Needles and Syringes Markets.

The trend toward patient self-administration of injectables continues to have a broad influence on the drug delivery sector. While prefillable syringe manufacturers continue to improve and refine their products, from a materials technology standpoint the most dynamic developments are occurring in the refinement of PFS constructed of plastic rather than glass. To date, plastic PFS have made significant inroads in EMS injectables, a segment dominated by Hospira’s Ansyr plastic PFS product line. Now, as materials technology continues to advance, market sector participants are targeting mainstream therapeutic drugs.

Highlights

– What injectable drugs are currently delivered in plastic prefillable syringes, what are the device specifics, and who markets them?
– Who are the important plastic prefillable syringe suppliers, their manufacturing infrastructure and locations, their capabilities?
– What are the major factors driving plastic prefillable syringe demand?
– How important are drug developer-device manufacturer relationships and what are the key alliances in the industry?
– What are the essential design factors, material selection issues, technologies and market development issues for plastic prefillable syringe drug products?
– How are plastic prefillable syringes aligned with various drug classes and therapeutic markets?
– What are the significant economic, technology, and regulatory factors affecting plastic prefillable syringes?

Read more and order at Plastic Prefillable Syringes

Read More

Plastic Prefillable Syringes – Healthcare, Medical Devices, Needles and Syringes Industries

The Plastic Prefillable Syringes Report has been published. It provides updated in 2018 year analysis of industries from Healthcare, Medical Devices, Needles and Syringes Markets.

The trend toward patient self-administration of injectables continues to have a broad influence on the drug delivery sector. While prefillable syringe manufacturers continue to improve and refine their products, from a materials technology standpoint the most dynamic developments are occurring in the refinement of PFS constructed of plastic rather than glass. To date, plastic PFS have made significant inroads in EMS injectables, a segment dominated by Hospira’s Ansyr plastic PFS product line. Now, as materials technology continues to advance, market sector participants are targeting mainstream therapeutic drugs.

Highlights

– What injectable drugs are currently delivered in plastic prefillable syringes, what are the device specifics, and who markets them?
– Who are the important plastic prefillable syringe suppliers, their manufacturing infrastructure and locations, their capabilities?
– What are the major factors driving plastic prefillable syringe demand?
– How important are drug developer-device manufacturer relationships and what are the key alliances in the industry?
– What are the essential design factors, material selection issues, technologies and market development issues for plastic prefillable syringe drug products?
– How are plastic prefillable syringes aligned with various drug classes and therapeutic markets?
– What are the significant economic, technology, and regulatory factors affecting plastic prefillable syringes?

Read more and order at Plastic Prefillable Syringes

Read More

North America Single-Use Medical Device Reprocessing Market – Growth, Trends, and Forecasts 2017 – 2022 – Healthcare, Medical Devices Industries

The North America Single-Use Medical Device Reprocessing Market – Growth, Trends, and Forecasts 2017 – 2022 Report has been published. It provides updated in 2018 year analysis of industries from Healthcare, Medical Devices Markets.

In the year 2016, the North America Single-Use Medical Device (SUD) reprocessing market was valued at USD XX million and it is expected to reach a market value of USD XX million by the year 2021, growing at a CAGR of X.X% during the forecast period (2017 – 2022).

SUDs are meant for a single use but some of the SUDs can be used multiple times with proper reprocessing. Use of reprocessed SUDs is a common practice around the world and is particularly popular in emerging markets.

SUD reprocessing is strictly regulated in most developed countries with well-established protocols for reprocessing. However, the situation is quite opposite in emerging markets where in the regulators have little to no control over the SUD reprocessing. Only a limited number of SUDs are suitable for reprocessing and all SUDs cannot be reprocessed.

North America Single-Use Medical Device Reprocessing Market-Market Dynamics

The huge cost savings associated with the use of reprocessed SUDs along with the positive environmental impact of SUD reprocessing and low barrier to entry are driving the growth of this market. The preconceived notions regarding the quality of reprocessed SUDs along with reduction in manufacturer profits and the ability of hospitals to setup their own SUD reprocessing facilities are hindering the growth of this market.

Being able to reprocess only 2% of all the SUDs currently is a huge opportunity in this market, while the opposition from manufacturers is currently the major challenge faced by this market.

The North America SUD reprocessing market has been segmented on the basis of the device into Class-I and Class-II devices. The Class-I devices have been further segmented into sequential compression sleeves, tourniquet cuffs, and pulse oximeter sensors. The Class-II devices have been further segmented into microdebriders, cautery electrodes, laparoscopic graspers, scissors, forceps, scalpels, orthopedic blades, drill bits, external fixation clamps, and electrophysiological cardiac catheters.

Based on geography, this market has been segmented into the United States and Canada.

Major Companies in the Sector Include:

This Report Offers:

Market analysis for the North America single-use medical device reprocessing market, with region-specific assessments and competition analysis.

Market definition along with the identification of key drivers and restraints.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market.

Extensively researched competitive landscape section with profiles of major companies along with their market share.

Identification and analysis of the macro and micro factors that affect the market.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.

Read more and order at North America Single-Use Medical Device Reprocessing Market – Growth, Trends, and Forecasts 2017 – 2022

Read More

North America Single-Use Medical Device Reprocessing Market – Growth, Trends, and Forecasts 2017 – 2022 – Healthcare, Medical Devices Industries

The North America Single-Use Medical Device Reprocessing Market – Growth, Trends, and Forecasts 2017 – 2022 Report has been published. It provides updated in 2018 year analysis of industries from Healthcare, Medical Devices Markets.

In the year 2016, the North America Single-Use Medical Device (SUD) reprocessing market was valued at USD XX million and it is expected to reach a market value of USD XX million by the year 2021, growing at a CAGR of X.X% during the forecast period (2017 – 2022).

SUDs are meant for a single use but some of the SUDs can be used multiple times with proper reprocessing. Use of reprocessed SUDs is a common practice around the world and is particularly popular in emerging markets.

SUD reprocessing is strictly regulated in most developed countries with well-established protocols for reprocessing. However, the situation is quite opposite in emerging markets where in the regulators have little to no control over the SUD reprocessing. Only a limited number of SUDs are suitable for reprocessing and all SUDs cannot be reprocessed.

North America Single-Use Medical Device Reprocessing Market-Market Dynamics

The huge cost savings associated with the use of reprocessed SUDs along with the positive environmental impact of SUD reprocessing and low barrier to entry are driving the growth of this market. The preconceived notions regarding the quality of reprocessed SUDs along with reduction in manufacturer profits and the ability of hospitals to setup their own SUD reprocessing facilities are hindering the growth of this market.

Being able to reprocess only 2% of all the SUDs currently is a huge opportunity in this market, while the opposition from manufacturers is currently the major challenge faced by this market.

The North America SUD reprocessing market has been segmented on the basis of the device into Class-I and Class-II devices. The Class-I devices have been further segmented into sequential compression sleeves, tourniquet cuffs, and pulse oximeter sensors. The Class-II devices have been further segmented into microdebriders, cautery electrodes, laparoscopic graspers, scissors, forceps, scalpels, orthopedic blades, drill bits, external fixation clamps, and electrophysiological cardiac catheters.

Based on geography, this market has been segmented into the United States and Canada.

Major Companies in the Sector Include:

This Report Offers:

Market analysis for the North America single-use medical device reprocessing market, with region-specific assessments and competition analysis.

Market definition along with the identification of key drivers and restraints.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market.

Extensively researched competitive landscape section with profiles of major companies along with their market share.

Identification and analysis of the macro and micro factors that affect the market.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.

Read more and order at North America Single-Use Medical Device Reprocessing Market – Growth, Trends, and Forecasts 2017 – 2022

Read More

North America Single-Use Medical Device Reprocessing Market – Growth, Trends, and Forecasts 2017 – 2022 – Healthcare, Medical Devices Industries

The North America Single-Use Medical Device Reprocessing Market – Growth, Trends, and Forecasts 2017 – 2022 Report has been published. It provides updated in 2018 year analysis of industries from Healthcare, Medical Devices Markets.

In the year 2016, the North America Single-Use Medical Device (SUD) reprocessing market was valued at USD XX million and it is expected to reach a market value of USD XX million by the year 2021, growing at a CAGR of X.X% during the forecast period (2017 – 2022).

SUDs are meant for a single use but some of the SUDs can be used multiple times with proper reprocessing. Use of reprocessed SUDs is a common practice around the world and is particularly popular in emerging markets.

SUD reprocessing is strictly regulated in most developed countries with well-established protocols for reprocessing. However, the situation is quite opposite in emerging markets where in the regulators have little to no control over the SUD reprocessing. Only a limited number of SUDs are suitable for reprocessing and all SUDs cannot be reprocessed.

North America Single-Use Medical Device Reprocessing Market-Market Dynamics

The huge cost savings associated with the use of reprocessed SUDs along with the positive environmental impact of SUD reprocessing and low barrier to entry are driving the growth of this market. The preconceived notions regarding the quality of reprocessed SUDs along with reduction in manufacturer profits and the ability of hospitals to setup their own SUD reprocessing facilities are hindering the growth of this market.

Being able to reprocess only 2% of all the SUDs currently is a huge opportunity in this market, while the opposition from manufacturers is currently the major challenge faced by this market.

The North America SUD reprocessing market has been segmented on the basis of the device into Class-I and Class-II devices. The Class-I devices have been further segmented into sequential compression sleeves, tourniquet cuffs, and pulse oximeter sensors. The Class-II devices have been further segmented into microdebriders, cautery electrodes, laparoscopic graspers, scissors, forceps, scalpels, orthopedic blades, drill bits, external fixation clamps, and electrophysiological cardiac catheters.

Based on geography, this market has been segmented into the United States and Canada.

Major Companies in the Sector Include:

This Report Offers:

Market analysis for the North America single-use medical device reprocessing market, with region-specific assessments and competition analysis.

Market definition along with the identification of key drivers and restraints.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market.

Extensively researched competitive landscape section with profiles of major companies along with their market share.

Identification and analysis of the macro and micro factors that affect the market.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.

Read more and order at North America Single-Use Medical Device Reprocessing Market – Growth, Trends, and Forecasts 2017 – 2022

Read More